| 臺大學術典藏 |
2021-01-05T03:34:31Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Li C.-C.; Kuo Y.-Y.; Chen C.-Y.; Tang J.-L.; Tsai C.-H.; Hou H.-A.; Tien F.-M.; Lin C.-T.; MING YAO; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:30Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien H.-F.; Chou W.-C.; MING YAO; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Wu S.-J.; Lin C.-T.; Lin L.-I.; Liao X.-W.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Peng Y.-L.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:28Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Hou H.-A.; Chen C.-Y.; Chou W.-C.; Lin L.-I.; MING YAO; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T02:30:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Lin C.-T.; Li C.-C.; Yao M.; Chen C.-Y.; Tsai C.-H.; Kuo Y.-Y.; Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; SHENG-CHIEH CHOU; Tsay W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T00:56:44Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Tseng M.-H.; Chiou R.-J.; Huang C.-F.; SHANG-JU WU; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Ko B.-S.; Tsay W.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:40Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Ko B.-S.; Huang S.-Y.; Yao M.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:39Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Liu M.-C.; Liu C.-W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Lin C.-W.; Jhuang J.-Y.; Hou H.-A.; Cheng C.-L.; Tien H.-F.; Chen Y.-C.; Tsay W.; Chen C.-Y.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Huang S.-Y.; Yao M.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; SHANG-JU WU; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Kuo Y.-Y.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Tsay W.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; SHANG-JU WU; Liu C.-Y.; Chen C.-Y.; Tsay W.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Chen C.-Y.; Lin C.-C.; Lai Y.-J.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; SHANG-JU WU; Lin C.-T.; Chen C.-Y.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Lin C.-C.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Chiang Y.-C.; Tseng M.-H.; Chou W.-C.; Lin C.-C.; Lin T.-Y.; Yao C.-Y.; Hou H.-A.; Li C.-C.; Hsu S.-C.; Chen C.-Y.; Ko B.-S.; Lin C.-T.; Liao X.-W.; SHANG-JU WU; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:28Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Ko B.-S.; Huang S.-Y.; Li C.-C.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Kuo Y.-Y.; Chen C.-Y.; Chiu Y.-C.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Liao X.-W.; Lin L.-I.; Lin C.-T.; SHANG-JU WU; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tang J.-L.; Hou H.-A.; Tsai C.-H.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2021-01-05T00:56:25Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:44Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chen C.-Y.; Lin C.-W.; Jhuang J.-Y.; Cheng C.-L.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:34Z |
An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
|
HWEI-FANG TIEN; Chen Y.; Chuang E.Y.; Kuo Y.-Y.; Tseng M.-H.; Hou H.-A.; Chou W.-C.; Chiu Y.-C.; Chuang M.-K. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:24Z |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Chiang Y.-C.; Tseng M.-H.; Kuo Y.-Y.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tsai C.-H.; Lin T.-Y.; Hou H.-A.; Lu J.-W.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:23Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Ko B.-S.; Huang S.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Chen C.-Y.; Chou W.-C.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Kuo Y.-Y.; Wu S.-J.; Hou H.-A.; Tsai C.-H.; Hsu S.-C.; Lin C.-T.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:21Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HWEI-FANG TIEN; Chou W.-C.; Yao M.; Huang S.-Y.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:19Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Chiu Y.-C.; Kuo Y.-Y.; Tien F.-M.; Tang J.-L.; Yao C.-Y.; Tsai C.-H.; HWEI-FANG TIEN; Hou H.-A.; Chen C.-Y.; Lin L.-I.; Chou W.-C.; Yao M.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Lin C.-C.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:18Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Tseng M.-H.; HWEI-FANG TIEN; Huang S.-Y.; Chen C.-Y.; Hsu S.-C.; Wu S.-J.; Tsay W.; Yao M.; Li C.-C.; Tang J.-L.; Lin C.-T.; Ko B.-S.; Chou W.-C.; Hou H.-A.; Huang H.-H.; Chen F.-Y.; Chen R.-H. |
| 國立成功大學 |
2021 |
Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan
|
Chung, Chung C.-H.;Tsai, I.-J.;Tseng, M.-H.;Chou, H.-H.;Tain, Y.-L.;Tsai, J.-D.;Chiou, Y.-Y.;Chiou, Y.-H.;Lin, C.-Y. |
| 臺大學術典藏 |
2020-12-21T08:19:26Z |
Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan
|
Lin S.-H.; Wu T.-W.; Lee H.-J.; Tseng M.-H.;Tsai J.-D.;I-Jung Tsai;Huang S.-M.;Huang J.-L.;Fan W.-L.;Lee H.-J.;Wu T.-W.;Lin S.-H.; Tseng M.-H.; Tsai J.-D.; I-JUNG TSAI; Huang S.-M.; Huang J.-L.; Fan W.-L. |
| 臺大學術典藏 |
2020-12-09T01:16:02Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chieh-Lung Cheng; Hou, H-A; Jhuang, J-Y; Lin, C-W; Chen, C-Y; Tang, J-L; Chou, W-C; Tseng, M-H; Yao, M; Huang, S-Y; Ko, B-S; Hsu, S-C; Wu, S-J; Tsay, W; Chen, Y-C; Tien, H-F |
| 臺大學術典藏 |
2020-11-17T02:45:26Z |
A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes
|
Huang H.-H.; Hou H.-A.; Lin C.-C.; Tseng M.-H.; Kao C.-J.; TZU-PIN LU; Chou W.-C.; Tien H.-F.; Yao C.-Y.;Chen C.-H.;Huang H.-H.;Hou H.-A.;Lin C.-C.;Tseng M.-H.;Kao C.-J.;Tzu-Pin Lu;Chou W.-C.;Tien H.-F.; Yao C.-Y.; Chen C.-H. |
| 臺大學術典藏 |
2020-10-28T08:35:11Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Hou H.-A.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; CHENG-HONG TSAI; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2020-10-28T08:35:10Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
CHENG-HONG TSAI; Hou H.-A.; Tang J.-L.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2020-10-28T08:35:09Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Hou H.-A.; CHENG-HONG TSAI; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2020-10-28T08:35:09Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
CHENG-HONG TSAI; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-10-28T08:35:08Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F.; CHENG-HONG TSAI; Tang J.-L.; Chiu Y.-C.; Hou H.-A.; Tien F.-M. |
| 臺大學術典藏 |
2020-10-28T08:35:08Z |
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
|
Chou W.-C.; Tien H.-F.; Tseng M.-H.; CHENG-HONG TSAI; Lin C.-C.; Hou H.-A.; Kao C.-J.; Yang Y.-T.; Chiu Y.-C. |
| 臺大學術典藏 |
2020-10-28T08:35:08Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.; Hou H.-A.; CHENG-HONG TSAI; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2020-10-28T08:35:06Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Hou H.-A.; Tien H.-F.; Kuo Y.-Y.; Tang J.-L.; Yao C.-Y.; Tien F.-M.; CHENG-HONG TSAI; Chen C.-Y.; Lin L.-I.; Chou W.-C.; Yao M.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Lin C.-C.; Chiu Y.-C. |
| 臺大學術典藏 |
2020-10-20T01:45:47Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Tien H.-F.; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Tang J.-L.; Chou W.-C.; Chen C.-Y.; Liu C.-Y.; Lin L.-I.; TAI-CHUNG HUANG; Hou H.-A. |
